Síndrome de Hiper-IgM en miembros de 2 familias chilenas no relacionadas: Análisis genético-molecular

Background: Hyper-IgM syndrome (HIGM) is a rare primary immunodeficiency used to describe a heterogeneous group of disorders characterized by recurrent bacterial infections, normal or elevated serum IgM levels and low or absent serum IgG, IgA and IgE. Aim: To make definitive diagnosis, detect mutati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Luttges D,Pamela, Retamal F,David, Spencer Y,Michael, Carrión A,Flavio, Valenzuela M,Viviana, Navarro V,Sara, Cornejo De L,Mónica
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2004
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004001000004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Background: Hyper-IgM syndrome (HIGM) is a rare primary immunodeficiency used to describe a heterogeneous group of disorders characterized by recurrent bacterial infections, normal or elevated serum IgM levels and low or absent serum IgG, IgA and IgE. Aim: To make definitive diagnosis, detect mutations in carriers and perform genetic counseling in patients with HIGM. Patients and methods: We studied the expression of CD40L, CD40 and made a mutation analysis of the CD40L gene in 3 males of 2 unrelated Chilean families diagnosed as a possible syndrome of hyper-IgM and 3 relatives. Results: We identified a deletion frameshift in the exon 2 (delA225) of the extracellular domain of CD40L gene in one patient and verified the carrier status of his mother and sister. The other patients showed a low expression of CD40L in activated T cells (65.3% and 65.5%) and a normal expression of CD40. No alterations were found in the single strand conformation polymorphism analysis of the CD40L. Conclusions: These result allowed us to make a definitive diagnosis of HIGM1 of a patient, detect female carriers and suggest a HIGM of recessive inheritance with normal CD40 expression in the patients of the second family (Rev Méd Chile 2004; 132: 1179-88)